Cas no 1001757-54-5 (4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine)
4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine Chemical and Physical Properties
Names and Identifiers
-
- 4-Chloro-1-(4-chloro-benzyl)-1 H -pyrazol-3-ylamine
- AKOS B001319
- ART-CHEM-BB B001319
- 4-CHLORO-1-(4-CHLOROBENZYL)-1H-PYRAZOL-3-AMINE
- 4-CHLORO-1-(4-CHLORO-BENZYL)-1H-PYRAZOL-3-YLAMINE
- 4-Chloro-1-[(4-chlorophenyl)methyl]-1H-pyrazol-3-amine
- 4-chloro-1-[(4-chlorophenyl)methyl]pyrazol-3-amine
- AKOS000304558
- 1001757-54-5
- DTXSID001207813
- BBL039151
- STK313071
- 4-Chloro-1-(4-chlorobenzyl)-1,2-dihydro-3h-pyrazol-3-imine
- EN300-227886
- CS-0268204
- 4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine
-
- MDL: MFCD02254018
- Inchi: 1S/C10H9Cl2N3/c11-8-3-1-7(2-4-8)5-15-6-9(12)10(13)14-15/h1-4,6H,5H2,(H2,13,14)
- InChI Key: ZFZPHVSIYOKUAK-UHFFFAOYSA-N
- SMILES: ClC1C(N)=NN(C=1)CC1C=CC(=CC=1)Cl
Computed Properties
- Exact Mass: 241.0173527Da
- Monoisotopic Mass: 241.0173527Da
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 15
- Rotatable Bond Count: 2
- Complexity: 207
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.7
- Topological Polar Surface Area: 43.8?2
Experimental Properties
- Density: 1.4±0.1 g/cm3
- Boiling Point: 410.4±40.0 °C at 760 mmHg
- Flash Point: 202.0±27.3 °C
- Vapor Pressure: 0.0±1.0 mmHg at 25°C
4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine Security Information
- Signal Word:warning
- Hazard Statement: H303+H313+H333
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | C383188-10mg |
4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine |
1001757-54-5 | 10mg |
$ 50.00 | 2022-06-06 | ||
| TRC | C383188-50mg |
4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine |
1001757-54-5 | 50mg |
$ 105.00 | 2022-06-06 | ||
| TRC | C383188-100mg |
4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine |
1001757-54-5 | 100mg |
$ 160.00 | 2022-06-06 | ||
| Fluorochem | 030551-250mg |
4-Chloro-1-(4-chloro-benzyl)-1 H -pyrazol-3-ylamine |
1001757-54-5 | 250mg |
£160.00 | 2022-03-01 | ||
| Fluorochem | 030551-1g |
4-Chloro-1-(4-chloro-benzyl)-1 H -pyrazol-3-ylamine |
1001757-54-5 | 1g |
£363.00 | 2022-03-01 | ||
| Fluorochem | 030551-2g |
4-Chloro-1-(4-chloro-benzyl)-1 H -pyrazol-3-ylamine |
1001757-54-5 | 2g |
£638.00 | 2022-03-01 | ||
| Fluorochem | 030551-5g |
4-Chloro-1-(4-chloro-benzyl)-1 H -pyrazol-3-ylamine |
1001757-54-5 | 5g |
£963.00 | 2022-03-01 | ||
| Chemenu | CM483131-1g |
4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine |
1001757-54-5 | 97% | 1g |
$109 | 2022-06-14 | |
| Chemenu | CM483131-5g |
4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine |
1001757-54-5 | 97% | 5g |
$392 | 2022-06-14 | |
| Enamine | EN300-227886-0.05g |
4-chloro-1-[(4-chlorophenyl)methyl]-1H-pyrazol-3-amine |
1001757-54-5 | 95% | 0.05g |
$112.0 | 2024-06-20 |
4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine Related Literature
-
Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
-
Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
-
3. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
-
Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
Additional information on 4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine
4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine: A Comprehensive Overview
4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine (CAS No. 1001757-54-5) is a compound of significant interest in the field of organic chemistry and pharmacology. This compound, with its unique structure and properties, has been the subject of extensive research in recent years. The molecule consists of a pyrazole ring substituted with chlorine atoms and a benzyl group, making it a versatile compound with potential applications in drug discovery and material science.
The synthesis of 4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine involves a series of well-defined chemical reactions. Researchers have explored various methods to optimize the synthesis process, ensuring high yield and purity. Recent studies have focused on green chemistry approaches, utilizing catalysts and mild reaction conditions to minimize environmental impact. These advancements have not only improved the synthesis efficiency but also opened new avenues for large-scale production.
One of the most notable aspects of this compound is its pharmacological activity. Preclinical studies have demonstrated its potential as an anti-inflammatory agent, antioxidant, and anticancer drug. The compound's ability to inhibit key enzymes involved in inflammatory pathways makes it a promising candidate for treating chronic inflammatory diseases. Additionally, its antioxidant properties suggest potential applications in combating oxidative stress-related disorders.
In the context of cancer research, 4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine has shown remarkable activity against various cancer cell lines. Studies indicate that the compound induces apoptosis in cancer cells by modulating mitochondrial function and activating caspase pathways. Furthermore, its ability to inhibit tumor angiogenesis highlights its potential as an antiangiogenic agent, which could be beneficial in treating metastatic cancers.
The compound's structure also lends itself to applications in the field of material science. Its aromaticity and conjugated system make it suitable for use in organic electronics, such as in the development of semiconductors and light-emitting diodes (LEDs). Recent research has explored its use as a building block for constructing advanced materials with tailored electronic properties.
Despite its promising applications, further research is needed to fully understand the compound's mechanisms of action and toxicity profile. Ongoing studies are investigating its pharmacokinetics, bioavailability, and potential side effects to ensure its safety for therapeutic use. Collaborative efforts between chemists, biologists, and pharmacologists are expected to unlock new insights into this compound's potential.
In conclusion, 4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine (CAS No. 1001757-54-5) is a multifaceted compound with diverse applications across various scientific disciplines. Its unique chemical structure, coupled with recent advancements in synthesis and biological studies, positions it as a valuable tool in drug discovery and material science. As research continues to unfold, this compound is poised to make significant contributions to both academic and industrial sectors.
1001757-54-5 (4-Chloro-1-(4-chlorobenzyl)-1H-pyrazol-3-amine) Related Products
- 10199-67-4(N-Benzylpyrazole)
- 3524-31-0(1-(Pyridin-4-ylmethyl)-1H-pyrazol-5-amine)
- 3524-13-8(1-(1-Phenylethyl)-1H-pyrazol-5-amine)
- 143128-30-7(1-(4-iodobenzyl)-1H-pyrazole)
- 142335-61-3(4-(1H-Pyrazol-1-ylmethyl)aniline)
- 122800-01-5(3-Amino-1-benzyl-1H-pyrazole-4-carbonitrile)
- 3524-29-6(1-{4-(propan-2-yl)phenylmethyl}-1H-pyrazol-5-amine)
- 3528-51-6(2-benzylpyrazol-3-amine)
- 179057-34-2(4-(1H-Pyrazol-1-ylmethyl)benzonitrile)
- 28466-62-8(1-Benzyl-1H-pyrazol-4-amine)